New Clot-Blocking drug tested in healthy people for first time
NCT ID NCT06665828
First seen Jan 11, 2026 · Last updated May 24, 2026 · Updated 21 times
Summary
This early-stage study tested a new drug called REGN9533 in 72 healthy adults to see if it is safe and how the body handles it. The drug targets a clotting protein and may one day help prevent dangerous blood clots. No treatment was given—this trial only gathered safety and dosing information for future studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
SGS Belgium NV_Edegem
Edegem, Antwerp, 2650, Belgium
Conditions
Explore the condition pages connected to this study.